Papers
1
Total Citations
2
H-Index
1
About
G Carli is a leading figure in urologic oncology, with a focused expertise in nephron-sparing surgery for renal tumors. His work centers on optimizing outcomes for patients with solitary kidneys, a high-stakes scenario where preserving renal function is as critical as achieving oncologic control. Carli’s major contribution lies in advancing the evidence base for robot-assisted partial nephrectomy (RAPN), demonstrating through prospective data that this minimally invasive approach can safely balance functional preservation with effective tumor removal. His 2025 study, drawing from a large, prospectively maintained dataset at a single tertiary referral center, provides robust, real-world evidence that RAPN reduces morbidity without compromising cancer control in these vulnerable patients. While his most-cited paper has garnered 2 citations, its impact is growing as the field increasingly prioritizes quality-of-life outcomes. Carli’s work is notable for its rigorous methodology and its direct clinical relevance, offering surgeons a validated framework for managing complex renal tumors. For students and researchers, Carli exemplifies how targeted, high-quality research can translate into improved surgical practice and patient care in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1